Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1502, 2005-01, pp. : 17-18
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Managing ART complications: tenofovir a good choice
Reactions Weekly, Vol. 1, Iss. 1064, 2005-01 ,pp. :
Access to resources
Recommend
Levofloxacin good choice in CAP
Inpharma, Vol. 1, Iss. 1428, 2004-01 ,pp. :
MDOT a good choice for poor HAART adherence
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 514, 2006-01 ,pp. :
Lopinavir/ritonavir superior choice for ART-experienced patients
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 514, 2006-01 ,pp. :
Renal Complications of Sickle Cell Disease: Managing for Optimal Outcomes
Pediatric Drugs, Vol. 4, Iss. 1, 2002-01 ,pp. :